TRIS (Tris(2,3-dibromopropyl) phosphate)

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• IARC Monographs Volume 52: Tris(2,3-dibromopropyl) Phosphate (TRIS) — Group 2B Carcinogen, Genotoxicity (Ames Assay), Kidney Tumors in Rodents, DBPA Metabolite, DNA Alkylation Mechanism (1999) REGULATORY · 1999
• US Consumer Product Safety Commission (CPSC): Ban on Tris(2,3-dibromopropyl) Phosphate in Children's Sleepwear (16 CFR Part 1209), Dermal Absorption in Children, Urinary DBPA Metabolite Detection, FHSA Basis, Landmark Flame Retardant Regulation (1977) REGULATORY · 1977
• PROPOSITION 65 LIST OF CARCINOGENS OR REPRODUCTIVE TOXICANTS REGULATORY · 2026
• IARC Monographs, List of Classifications REGULATORY · 2026
• where to look PubChem: Toxicity section (CID 31356) PUBCHEM
• TEDX List of Potential Endocrine Disruptors, full export (Excel from the publisher's own search, operator-saved 2026-10-08; list last updated September 2018) REFERENCE_DATABASE
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• where to look CAMEO Chemicals, as recorded by PubChem (Experimental Properties, CID 31356; where-to-look, not a source of this value) DATABASE · 2026
• EPA CompTox CTX API: predicted properties for DTXSID5021413 (TRIS (Tris(2,3-dibromopropyl) phosphate)) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.